You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BCAX Sale Disclosure
Mazumdar Claire · SEC Form 4 · Filed Jul 14, 2026
Sale
Calculated transaction value
$831.04
Mazumdar Claire Chief Executive Officer
BCAX
Transaction date
Jul 10, 2026
Public filing date
Jul 14, 2026
Filing lag
Filed 4 days later
BCAX daily price context
Close on/before transaction
$28.91
Jul 10, 2026
First close after public filing
$28.11
Jul 15, 2026
30-day return after filing
-15.95%
Through Aug 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 28 shares @ $29.68
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001470831-26-000714
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$322.1K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bicara Therapeutics Inc. BCAX | Exercise | Jul 10, 2026 | $37.9K |
| Bicara Therapeutics Inc. BCAX | Sale | Jul 10, 2026 | $283.37K |
| Bicara Therapeutics Inc. BCAX Current | Sale | Jul 10, 2026 | $831.04 |
| Bicara Therapeutics Inc. BCAX | Exercise | Jul 10, 2026 | $0 |